Loading...
•
Jun 30, 2020
Allovir Q2 2020 Earnings Report
AlloVir reported financial results for the second quarter ended June 30, 2020.
Key Takeaways
AlloVir reported a net loss of $11.6 million, or $4.43 per share, for the quarter ended June 30, 2020. The company's cash, cash equivalents, and marketable securities totaled $104.5 million as of June 30, 2020. They closed an initial public offering raising $317.7mm in gross proceeds in August.
Research and development expenses were $8.9 million, up from $2.8 million year-over-year.
General and administrative expense was $3.3 million, slightly up from $3.2 million year-over-year.
Cash, cash equivalents, and marketable securities were $104.5 million.
Net loss was $11.6 million, or $4.43 per share, compared to a net loss of $5.3 million, or $5.05 per share, year-over-year.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...